8-K Announcements
6Material company update
Apr 28, 2026·SEC
Material company update
Feb 4, 2026·SEC
Material company update
Jan 7, 2026·SEC
Omega Healthcare Investors, Inc.(OHI)Earnings, Financials & Key Ratios
OHI•NYSE•REIT / Real Estate
23.0× P/E·Price updated Jun 19, 2026
AboutOmega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.Show more
- Revenue$1.2B+14.0%
- FFO$915M+28.7%
- FFO/Share2.95+12.1%
- FFO Payout85.25%-11.6%
- FFO per Share2.95+12.1%
- NOI Margin44.5%-54.9%
- FFO Margin76.4%+13.0%
- ROE11.6%+21.3%
- ROA5.92%+38.4%
OHI Key Insights
Omega Healthcare Investors, Inc. (OHI) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong 5Y profit CAGR of 29.9%
- ✓FFO growing 26.9% TTM
- ✓Healthy dividend yield of 5.6%
✗Weaknesses
- ✗Dividend payout exceeds 100% of earnings
- ✗Shares diluted 14.9% in last year
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when OHI posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
OHI Price & Volume
Omega Healthcare Investors, Inc. (OHI) stock price & volume — 10-year historical chart
Loading chart...
OHI Growth Metrics
Omega Healthcare Investors, Inc. (OHI) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years4.89%
5 Years6.07%
3 Years10.91%
TTM14.19%
Profit CAGR
10 Years10.15%
5 Years29.94%
3 Years11.39%
TTM41.09%
EPS CAGR
10 Years4.16%
5 Years23.33%
3 Years2.53%
TTM28.57%
Return on Capital
10 Years5.92%
5 Years6.18%
3 Years6.84%
Last Year7.88%
OHI Recent Earnings
Omega Healthcare Investors, Inc. (OHI) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 11/12 qtrs (92%)●Beat Revenue 10/12 qtrs (83%)
Q2 2026Latest
Apr 28, 2026Metric
Actual
Est
EPS
$0.82+69.2%
$0.48
Rev
$267M+1.1%
$264M
Q1 2026
Feb 4, 2026Metric
Actual
Est
EPS
$0.55+11.1%
$0.50
Rev
$261M-1.2%
$265M
Q4 2025
Oct 30, 2025Metric
Actual
Est
EPS
$0.79+2.6%
$0.77
Rev
$312M+8.5%
$287M
Q3 2025
Jul 31, 2025Metric
Actual
Est
EPS
$0.77+2.7%
$0.75
Rev
$283M+14.0%
$248M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 28, 2026 | $0.82vs $0.48+69.2% | $267Mvs $264M+1.1% |
| Q1 2026 | Feb 4, 2026 | $0.55vs $0.50+11.1% | $261Mvs $265M-1.2% |
| Q4 2025 | Oct 30, 2025 | $0.79vs $0.77+2.6% | $312Mvs $287M+8.5% |
| Q3 2025 | Jul 31, 2025 | $0.77vs $0.75+2.7% | $283Mvs $248M+14.0% |
Based on last 12 quarters of dataView full earnings history →
OHI Peer Comparison
Omega Healthcare Investors, Inc. (OHI) competitors in Senior housing and skilled nursing — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 SBRA | 4.57B | 18.12 | 28.31 | 10.15% | 19.21% | 5.6% | 0.90 | |
 LTC | 1.86B | 36.37 | 14.43 | 25.26% | 39.08% | 10.9% | 0.73 | |
 CTRE | 8.76B | 37.06 | 23.61 | 108.79% | 71.55% | 8.63% | 0.22 | |
 NHI | 3.43B | 70.82 | 23.45 | 12.93% | 36.76% | 9.78% | 0.76 | |
 VTR | 38.8B | 81.61 | 151.13 | 18.47% | 4.25% | 2.08% | 1.05 | |
 WELL | 144.78B | 206.65 | 148.67 | 35.82% | 12.31% | 3.49% | 0.49 | |
 HR | 6.9B | 19.79 | -27.87 | -6.92% | -17.51% | -4.28% | 0.89 | |
 DOC | 13.6B | 19.56 | 195.60 | 4.52% | 7.73% | 2.6% | 1.26 |
Compare OHI vs Peers
Omega Healthcare Investors, Inc. (OHI) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
OHI Income Statement
Omega Healthcare Investors, Inc. (OHI) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 908.38M | 881.68M | 928.83M | 892.38M | 1.06B | 878.24M | 949.74M | 1.05B | 1.2B | 1.24B |
Revenue Growth % | 0.84% | -2.94% | 5.35% | -3.92% | 19.1% | -17.37% | 8.14% | 10.7% | 13.95% | 14.19% |
Property Operating Expenses | 0 | 0 | 14.93M | 12.32M | 12.26M | 15.5M | 15.03M | 14.56M | 664.93M | 180.21M |
Net Operating Income (NOI) | 908.38M▲ 0% | 881.68M▼ 2.9% | 913.9M▲ 3.7% | 880.07M▼ 3.7% | 1.05B▲ 19.4% | 862.74M▼ 17.9% | 934.72M▲ 8.3% | 1.04B▲ 10.9% | 533.17M▼ 48.6% | 1.06B▲ 0% |
NOI Margin % | 100% | 100% | 98.39% | 98.62% | 98.85% | 98.24% | 98.42% | 98.62% | 44.5% | 85.45% |
Operating Expenses | 593.21M | 384.09M | 362.15M | 427.81M | 484.38M | 470.47M | 445.74M | 377.17M | -216.27M | 175.22M |
G&A Expenses | 47.68M | 63.51M | 57.87M | 59.89M | 64.63M | 69.4M | 81.5M | 88M | 0 | 62.61M |
EBITDA | 602.76M | 778.87M | 853.43M | 782.18M | 908.19M | 724.68M | 808.65M | 964.31M | 1.07B | 1.13B |
EBITDA Margin % | 66.36% | 88.34% | 91.88% | 87.65% | 85.45% | 82.52% | 85.14% | 91.72% | 89.7% | 90.85% |
Depreciation & Amortization | 287.59M | 281.28M | 301.68M | 329.92M | 342.01M | 332.41M | 319.68M | 304.65M | 325.25M | 329.51M |
D&A / Revenue % | 31.66% | 31.9% | 32.48% | 36.97% | 32.18% | 37.85% | 33.66% | 28.98% | 27.15% | 26.6% |
Operating Income | 315.17M▲ 0% | 497.59M▲ 57.9% | 551.75M▲ 10.9% | 452.25M▼ 18.0% | 566.17M▲ 25.2% | 392.28M▼ 30.7% | 488.97M▲ 24.6% | 659.66M▲ 34.9% | 749.44M▲ 13.6% | 796.06M▲ 0% |
Operating Margin % | 34.7% | 56.44% | 59.4% | 50.68% | 53.27% | 44.67% | 51.48% | 62.74% | 62.55% | 64.26% |
Interest Expense | 220.24M | 201.42M | 208.72M | 223.39M | 234.6M | 233.24M | 235.53M | 221.72M | 220.53M | 4M |
Interest Coverage | 1.48x | 2.47x | 2.65x | 1.73x | 2.77x | 2.87x | 2.09x | 2.90x | 3.83x | - |
Non-Operating Income | -10.99M | -345K | -814K | 66.54M | -84.51M | -277.11M | -2.19M | 17.2M | -95.31M | -92.88M |
Pretax Income | 105.92M▲ 0% | 296.51M▲ 179.9% | 354.79M▲ 19.7% | 168.47M▼ 52.5% | 432.14M▲ 156.5% | 443.4M▲ 2.6% | 255.05M▼ 42.5% | 428.66M▲ 68.1% | 624.22M▲ 45.6% | 672.23M▲ 0% |
Pretax Margin % | 11.66% | 33.63% | 38.2% | 18.88% | 40.66% | 50.49% | 26.85% | 40.77% | 52.1% | 54.26% |
Income Tax | 3.25M | 3.01M | 2.84M | 4.92M | 3.84M | 4.56M | 6.25M | 10.86M | 14.75M | 16.24M |
Effective Tax Rate % | 3.07% | 1.02% | 0.8% | 2.92% | 0.89% | 1.03% | 2.45% | 2.53% | 2.36% | 2.42% |
Net Income | 100.42M▲ 0% | 281.58M▲ 180.4% | 341.12M▲ 21.1% | 159.33M▼ 53.3% | 416.74M▲ 161.6% | 426.93M▲ 2.4% | 242.18M▼ 43.3% | 406.33M▲ 67.8% | 590.11M▲ 45.2% | 632.09M▲ 0% |
Net Margin % | 11.05% | 31.94% | 36.73% | 17.85% | 39.21% | 48.61% | 25.5% | 38.65% | 49.25% | 51.02% |
Net Income Growth % | -72.59% | 180.4% | 21.15% | -53.29% | 161.56% | 2.44% | -43.27% | 67.78% | 45.23% | 41.09% |
Funds From Operations (FFO) | 388.01M▲ 0% | 562.86M▲ 45.1% | 642.81M▲ 14.2% | 489.25M▼ 23.9% | 758.75M▲ 55.1% | 759.33M▲ 0.1% | 561.86M▼ 26.0% | 710.97M▲ 26.5% | 915.36M▲ 28.7% | 961.6M▲ 0% |
FFO Margin % | 42.71% | 63.84% | 69.21% | 54.83% | 71.39% | 86.46% | 59.16% | 67.62% | 76.4% | 77.62% |
FFO Growth % | -38.75% | 45.06% | 14.2% | -23.89% | 55.08% | 0.08% | -26.01% | 26.54% | 28.75% | 107.38% |
FFO per Share | 1.88 | 2.68 | 2.89 | 2.08 | 3.11 | 3.11 | 2.24 | 2.63 | 2.95 | 3.05 |
FFO Payout Ratio % | 129.53% | 93.93% | 87.76% | 125.15% | 84.04% | 83.35% | 114.6% | 96.41% | 85.25% | 61.48% |
EPS (Diluted) | 0.51▲ 0% | 1.34▲ 162.7% | 1.54▲ 14.9% | 0.68▼ 55.8% | 1.75▲ 157.4% | 1.80▲ 2.9% | 1.00▼ 44.4% | 1.55▲ 55.0% | 1.94▲ 25.2% | 2.01▲ 0% |
EPS Growth % | -73.16% | 162.75% | 14.93% | -55.84% | 157.35% | 2.86% | -44.44% | 55% | 25.16% | 28.57% |
EPS (Basic) | 0.51 | 1.41 | 1.60 | 0.70 | 1.76 | 1.81 | 1.01 | 1.57 | 2.02 | - |
Diluted Shares Outstanding | 206.79M | 209.71M | 222.13M | 235.1M | 244.34M | 244.29M | 250.45M | 270.45M | 310.7M | 315.13M |
OHI Balance Sheet
Omega Healthcare Investors, Inc. (OHI) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Assets | 8.77B | 8.59B | 9.8B | 9.5B | 9.64B | 9.41B | 9.12B | 9.9B | 10.05B | 10.23B |
Asset Growth % | -1.97% | -2.08% | 14.03% | -3.05% | 1.48% | -2.42% | -3.06% | 8.56% | 1.53% | 36.86% |
Real Estate & Other Assets | 6.32B | 6.21B | 7.3B | 6.79B | 6.99B | 6.81B | 6.05B | 6.53B | 6.93B | -8.72B |
PP&E (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investment Securities | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
Total Current Assets | 1.5B | 1.2B | 1.23B | 1.39B | 1.81B | 1.77B | 2.23B | 2.64B | 2.06B | 1.42B |
Cash & Equivalents | 85.94M | 10.3M | 24.12M | 163.53M | 20.53M | 297.1M | 442.81M | 518.34M | 27.02M | 26.15M |
Receivables | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
Other Current Assets | 97.57M | 2.36M | 14.19M | 85.47M | 206.9M | 13M | 69.04M | 86.59M | 31.54M | 0 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 4.89B | 4.83B | 5.46B | 5.46B | 5.53B | 5.6B | 5.36B | 5.17B | 4.61B | 4.78B |
Total Debt | 4.57B | 4.54B | 5.14B | 5.17B | 5.25B | 5.29B | 5.07B | 4.84B | 4.26B | 4.44B |
Net Debt | 4.49B | 4.53B | 5.11B | 5.01B | 5.23B | 4.99B | 4.62B | 4.32B | 4.23B | 4.42B |
Long-Term Debt | 4.28B | 4.23B | 5.01B | 5.07B | 5.25B | 5.27B | 5.05B | 4.84B | 4.01B | 4.44B |
Short-Term Borrowings | 290M | 313M | 125M | 101.16M | 0 | 19.25M | 20.4M | 0 | 242M | 0 |
Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 585.14M | 585.17M | 437.04M | 381.98M | 276.72M | 334.29M | 308.19M | 328.19M | 594.55M | 0 |
Accounts Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Liabilities | 0 | 0 | 0 | 0 | -8.2M | 0 | 0 | 0 | 0 | 338.24M |
Total Equity | 3.89B▲ 0% | 3.76B▼ 3.2% | 4.34B▲ 15.2% | 4.04B▼ 6.9% | 4.11B▲ 1.8% | 3.8B▼ 7.4% | 3.76B▼ 1.1% | 4.73B▲ 25.7% | 5.44B▲ 15.0% | 5.46B▲ 0% |
Equity Growth % | -7.69% | -3.18% | 15.2% | -6.92% | 1.77% | -7.42% | -1.08% | 25.74% | 15% | 77.81% |
Shareholders Equity | 3.56B | 3.44B | 4.14B | 3.84B | 3.91B | 3.61B | 3.57B | 4.54B | 5.18B | 5.19B |
Minority Interest | 333.17M | 320.04M | 201.17M | 194.73M | 201.39M | 193.91M | 187.71M | 194.17M | 259.2M | 263.54M |
Common Stock | 19.83M | 20.23M | 22.66M | 23.12M | 23.91M | 23.43M | 24.53M | 27.91M | 29.55M | 29.78M |
Additional Paid-in Capital | 4.94B | 5.07B | 5.99B | 6.15B | 6.43B | 6.31B | 6.67B | 7.92B | 8.69B | 8.78B |
Retained Earnings | -1.37B | -1.61B | -1.84B | -2.32B | -2.54B | -2.75B | -3.15B | -3.43B | -3.62B | -3.67B |
Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Return on Assets (ROA) | 1.13% | 3.24% | 3.71% | 1.65% | 4.36% | 4.48% | 2.61% | 4.27% | 5.92% | 6.1% |
Return on Equity (ROE) | 2.48% | 7.36% | 8.42% | 3.81% | 10.23% | 10.79% | 6.4% | 9.57% | 11.6% | 11.85% |
Debt / Assets | 52.11% | 52.85% | 52.43% | 54.43% | 54.51% | 56.21% | 55.58% | 48.89% | 42.35% | 43.4% |
Debt / Equity | 1.18x | 1.21x | 1.18x | 1.28x | 1.28x | 1.39x | 1.35x | 1.02x | 0.78x | 0.81x |
Net Debt / EBITDA | 7.44x | 5.82x | 5.99x | 6.40x | 5.76x | 6.89x | 5.72x | 4.48x | 3.94x | 3.92x |
Book Value per Share | 18.80 | 17.95 | 19.52 | 17.17 | 16.81 | 15.57 | 15.02 | 17.49 | 17.51 | 17.31 |
OHI Cash Flow Statement
Omega Healthcare Investors, Inc. (OHI) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 577.91M | 499.37M | 553.75M | 708.26M | 722.14M | 625.73M | 626.54M | 749.43M | 878.55M | 912.1M |
Operating CF Growth % | -7.65% | -13.59% | 10.89% | 27.9% | 1.96% | -13.35% | 0.13% | 19.61% | 17.23% | 70.76% |
Operating CF / Revenue % | 63.62% | 56.64% | 59.62% | 79.37% | 67.95% | 71.25% | 65.97% | 71.28% | 73.33% | 73.62% |
Net Income | 104.91M | 293.88M | 351.95M | 163.54M | 428.3M | 438.84M | 241.72M | 417.8M | 609.47M | 632.09M |
Depreciation & Amortization | 287.59M | 281.28M | 301.68M | 329.92M | 342.01M | 332.41M | 319.68M | 304.65M | 325.25M | 329.51M |
Stock-Based Compensation | 15.21M | 15.99M | 15.36M | 18.82M | 21.41M | 27.3M | 0 | 36.7M | 44.19M | 38.97M |
Other Non-Cash Items | 1.69M | -1.64M | 3.67M | -2.55M | 35.12M | -127.24M | 80.24M | -42.57M | -97.4M | 40.2M |
Working Capital Changes | -89.43M | -127.88M | -124.06M | -30.84M | -94.03M | -45.58M | -15.1M | 32.85M | -2.95M | 15.56M |
Cash from Investing | -285.13M | -173.22M | -378.95M | -89.06M | -524.17M | 442.85M | -9.78M | -671.16M | -539.79M | -829.07M |
Acquisitions (Net) | 2.34M | 201.09M | -163.58M | -10.03M | -16.21M | -113K | -202K | -971K | -122.09M | -14.97M |
Purchase of Investments | -139.05M | -385.71M | -100.31M | -167.94M | -164.79M | -619.22M | -739.92M | 0 | 0 | 0 |
Sale of Investments | 95.7M | 181.37M | 91.28M | 149.87M | 111.11M | 759.05M | 750.22M | 8.43M | 4.24M | 38.73M |
Other Investing | -157.43M | -30.54M | -66.67M | 14.15M | -359.21M | 350.36M | 18.14M | -678.62M | -421.94M | -852.83M |
Cash from Financing | -303.81M | -410.7M | -153.96M | -485.55M | -341.12M | -789.45M | -473.31M | 26.32M | -838.26M | -436.24M |
Dividends Paid | -502.6M | -528.7M | -564.13M | -612.31M | -637.65M | -632.89M | -643.87M | -685.45M | -780.39M | -789.59M |
Common Dividends | -502.6M | -528.7M | -564.13M | -612.31M | -637.65M | -632.89M | -643.87M | -685.45M | -780.39M | -591.17M |
Debt Issuance (Net) | 1000K | 1000K | -1000K | 1000K | 1000K | 1000K | -1000K | -1000K | -1000K | -1000K |
Share Repurchases | -48K | -134K | 0 | 0 | 0 | -142.27M | 0 | 0 | 0 | -2.09M |
Other Financing | -17.25M | 21.65M | -25.85M | -39.15M | -74.3M | -22.4M | 62.07M | -36.41M | -81.96M | 212.59M |
Net Change in Cash | -10.47M▲ 0% | -85.14M▼ 713.3% | 21.71M▲ 125.5% | 134.18M▲ 518.1% | -143.15M▼ 206.7% | 276.23M▲ 293.0% | 144.09M▼ 47.8% | 104M▼ 27.8% | -494.17M▼ 575.1% | -350.75M▲ 0% |
Exchange Rate Effect | 568K | -590K | 874K | 527K | 7K | -2.9M | 430K | -580K | 5.33M | 3.5M |
Cash at Beginning | 107.28M | 96.81M | 11.67M | 33.38M | 167.56M | 24.41M | 300.64M | 444.73M | 548.74M | 54.56M |
Cash at End | 96.81M | 11.67M | 33.38M | 167.56M | 24.41M | 300.64M | 444.73M | 548.74M | 54.56M | 53.32M |
Free Cash Flow | 491.22M▲ 0% | 359.93M▼ 26.7% | 414.07M▲ 15.0% | 633.14M▲ 52.9% | 627.07M▼ 1.0% | 578.51M▼ 7.7% | 588.53M▲ 1.7% | 712.69M▲ 21.1% | 878.55M▲ 23.3% | 912.41M▲ 0% |
FCF Growth % | -11.78% | -26.73% | 15.04% | 52.91% | -0.96% | -7.74% | 1.73% | 21.1% | 23.27% | 24.96% |
FCF / Revenue % | 54.08% | 40.82% | 44.58% | 70.95% | 59% | 65.87% | 61.97% | 67.79% | 73.33% | 73.65% |
OHI Key Ratios
Omega Healthcare Investors, Inc. (OHI) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
FFO per Share | 1.88 | 2.68 | 2.89 | 2.08 | 3.11 | 3.11 | 2.24 | 2.63 | 2.95 | 3.05 |
FFO Payout Ratio | 129.53% | 93.93% | 87.76% | 125.15% | 84.04% | 83.35% | 114.6% | 96.41% | 85.25% | 61.48% |
NOI Margin | 100% | 100% | 98.39% | 98.62% | 98.85% | 98.24% | 98.42% | 98.62% | 44.5% | 85.45% |
Net Debt / EBITDA | 7.44x | 5.82x | 5.99x | 6.40x | 5.76x | 6.89x | 5.72x | 4.48x | 3.94x | 3.92x |
Debt / Assets | 52.11% | 52.85% | 52.43% | 54.43% | 54.51% | 56.21% | 55.58% | 48.89% | 42.35% | 43.4% |
Interest Coverage | 1.48x | 2.47x | 2.65x | 1.73x | 2.77x | 2.87x | 2.09x | 2.90x | 3.83x | - |
Book Value / Share | 18.8 | 17.95 | 19.52 | 17.17 | 16.81 | 15.57 | 15.02 | 17.49 | 17.51 | 17.31 |
Revenue Growth | 0.84% | -2.94% | 5.35% | -3.92% | 19.1% | -17.37% | 8.14% | 10.7% | 13.95% | 14.19% |
Related:OHI Dividend History·OHI Revenue History·OHI Price History·OHI P/E History·OHI Financial Ratios·OHI Institutional Holders
OHI SEC Filings & Documents
Omega Healthcare Investors, Inc. (OHI) SEC filings — annual & quarterly reports (10-K, 10-Q)
OHI Frequently Asked Questions
Omega Healthcare Investors, Inc. (OHI) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Omega Healthcare Investors, Inc. (OHI) reported $1.24B in revenue for fiscal year 2025. This represents a 1594% increase from $73.1M in 1996.
Omega Healthcare Investors, Inc. (OHI) grew revenue by 14.0% over the past year. This is steady growth.
Yes, Omega Healthcare Investors, Inc. (OHI) is profitable, generating $632.1M in net income for fiscal year 2025 (49.3% net margin).
Dividend & Returns
Yes, Omega Healthcare Investors, Inc. (OHI) pays a dividend with a yield of 5.64%. This makes it attractive for income-focused investors.
Omega Healthcare Investors, Inc. (OHI) has a return on equity (ROE) of 11.6%. This is reasonable for most industries.
Industry Metrics
Omega Healthcare Investors, Inc. (OHI) generated Funds From Operations (FFO) of $961.6M in the trailing twelve months. FFO is the primary profitability metric for REITs.
Omega Healthcare Investors, Inc. (OHI) offers a 5.64% dividend yield, which is attractive for income investors. REITs are required to distribute at least 90% of taxable income to shareholders.